At a glance
ClinicalIndex Comparison RecordN/ACompleted· 224 enrolled
Drug / intervention
GP0109device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multicenter Study to Evaluate Effectiveness and Safety of GP0109 for Jawline Definition
In Brief
A clinical study evaluating GP0109 for Jawline Definition Deficiency. Completed, enrolled 224 participants across 1 site.
Detailed Summary
This study is designed to evaluate effectiveness and safety of GP0109 for Jawline definition
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsJawline Definition Deficiency
CountriesPuerto Rico
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartNov 2021
Primary CompletionMar 2023
Study CompletionOct 2024
TodayJul 2026
First PostedNov 5, 2021
Enrollment StartNov 15, 2021
Primary CompletionMar 15, 2023
Study CompletionOct 23, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.7 years ago
Interventions
GP0109device
Treatment of the Jawline